February 20th, 2018 “If the results from the trials at Johns Hopkins and NYU are positive, we will apply to the National Institutes for Health for a grant to conduct a larger, multi-site trial of psilocybin for anxiety and depression in patients with advanced cancer,” says Grob. And again, as Grob explains, the prompt for this direction of enqu… Read More